ZOLL First Company to Receive Premarket Approval From The FDA on its Full Portfolio of Defibrillators

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that it is the first company to achieve premarket approval (PMA) by the U.S. Food and Drug Administration (FDA) to continue to market and distribute its full line of defibrillators in the U.S. The list of defibrillators which received PMA approval include the R Series and X Series monitor/defibrillators and the AED Pro and AED Plus automated external defibrillators. All of these devices are equipped with ZOLL’s proprietary rectilinear biphasic waveform to deliver maximum current to high-impedance patients and Real CPR Help technology that helps rescuers perform high-quality CPR.
Source: JEMS Patient Care - Category: Emergency Medicine Authors: Tags: Cardiac & Resuscitation Industry News Source Type: news